{
    "SPADE_N_13612": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13612",
            "Peptide Name": "Mytimacin-4 (natural AMPs; mollusca/molluscs/mollusks, marine invertebrates, animals; UCSS1)",
            "Source": "Mytilus galloprovinciali",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "NVIGDCWDDWSRCTRQTDWFTNIFWQSCQNRCKCKGQPGGNCIEVPSKCFLWKDKRWMCDCYGPTSGSKPWWCGF",
            "Sequence Length": 75,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 8883.04,
            "PI": 8.38,
            "Hydrophobicity": -0.73,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Lv J, Zhao J, Yang D, Wu H, Cong M.2019",
                    "Reference": "J Invertebr Pathol. 2019 Jul 9;166:107215. doi: 10.1016/j.jip.2019.107215.PubMed",
                    "Title": "Tissue distribution and functional characterization of mytimacin-4 in Mytilus galloprovincialis"
                }
            ],
            "Frequent Amino Acids": "CWG",
            "Absent Amino Acids": "AHOU",
            "Basic Residues": 10,
            "Acidic Residues": 7,
            "Hydrophobic Residues": 24,
            "Polar Residues": 40,
            "Positive Residues": 10,
            "Negative Residues": 7,
            "Net Charge": 3,
            "Comments": "Host expression: It is constitutively expressed in all of the tested tissues, including the hemocytes, hepatopancreas, gill, gonad, posterior adductor muscle and mantle. It can also be induced in the presence of pathogens.Sequence analysis: APD analysis reveals that the sequence of the peptide shows 66.7% similarity toMytimacin-AF. PI 8.38; GRAVY=-0.728; Mol Mass. 8883.162, Mol. Ext coeff: 45890, mol formula: C392H575N105O108S11.Activity: Active against Gram+ B. subtilis ATCC6633 (MIC 0.315 uM), S-aureus (MIC >1.24 uM), M. luteus ATCC4698 (MIC 1.24 uM), Gram- V-anguillarum KV9001, E-cloacae ATCC700323, P-putida ATCC49128, P-mirabilis ATCC25933 (MIC >1.24 uM), E. aerogenes ATCC13048 (MIC 1.24 uM), and V. parahaemolyticus ATCC17802 (MIC 0.62 uM). V. parahaemolyticus is a primary pathogen for the bivalve in the marine environment.Recombinant production:bacteria:Escherichia coli: IPTG induced expression, purification via Ni2+ chelating sepharose column, refolded in gradient urea-TBS glycerol buffer. Updated 7/2021",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15834",
                    "Similarity": 0.7066666666666667,
                    "Sequence": "TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL"
                }
            ]
        }
    }
}